Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine

Article Abstract:

A 29-year-old woman died from pulmonary hypertension and cardiac arrest that was apparently caused by the use of fenfluramine and phentermine. These drugs are appetite suppressants and are commonly called fen-phen when used together. The woman only used the drugs for 23 days and five months later was hospitalized for shortness of breath, swelling of her feet and two fainting episodes. Cardiac catheterization revealed pulmonary hypertension. When she died eight months after taking the drugs, an autopsy revealed lung changes characteristicly seen in patients taking appetite suppressants.

Author: Mark, Eugene J., Patalas, Eva D., Evans, Richard J., Chang, Howard T., Kessler, Stanton C.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1997
Causes of

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Appetite suppressants and valvular heart disease

Article Abstract:

People who have taken the diet pills fenfluramine or dexfenfluramine should have regular medical examinations to detect heart valve disease. These drugs first appeared in the 1990s, and seemed to be effective in the treatment of obesity. But in July, 1997, a paper was published reporting heart valve disease in 24 patients who had taken the drugs. The FDA subsequently ordered the drugs to be withdrawn from the market. Three 1998 studies confirm the link between these drugs and heart valve disease. However, the risk was low in patients who took the drugs for short periods of time.

Author: Devereux, Richard B.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
Editorial, Dexfenfluramine

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Valvular heart disease associated with fenfluramine-phentermine

Article Abstract:

Fenfluramine and phentermine may increase the risk of heart valve disease when used together. These drugs are appetite suppressants and are commonly called fen-phen when combined. Physicians identified 24 women taking fen-phen who developed heart valve disease. None had a history of heart disease. Eight of the women also had pulmonary hypertension. Five required surgery to replace one or more heart valves. In these women, the surgically removed valves were coated with a white plaque-like substance.

Author: Edwards, William D., McGoon, Michael D., Edwards, Brooks S., Schaff, Hartzell V., Connolly, Heidi M., Crary, Jack L., Hensrud, Donald D.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1997

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Complications and side effects, Pulmonary hypertension, Fenfluramine, Phentermine, Fen-phen diet, Fen-phen (Drug combination), Risk factors, Heart valve diseases
Similar abstracts:
  • Abstracts: Maternal serum vitamin A levels are not associated with mother-to-child transmission of HIV-1 in the United States
  • Abstracts: Disseminated Penicillium marneffei infection associated with human immunodeficiency virus: a report of two cases and a review of 35 published cases
  • Abstracts: Gender differences in risk behaviors associated with forced or pressured sex. Make love not war: violence and weapon carrying in music videos
  • Abstracts: Diagnosis of pulmonary embolism with magnetic resonance angiography. The evaluation of suspected pulmonary embolism
  • Abstracts: Transient high titers of HIV-1 in plasma and progression of disease. Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.